Editorial: Organ support in cardiac intensive care
Guo-wei Tu,Sascha Treskatsch,Takatoshi Kasai
DOI: https://doi.org/10.3389/fcvm.2024.1510197
IF: 3.6
2024-11-01
Frontiers in Cardiovascular Medicine
Abstract:Severe heart disease can trigger a cascade of systemic organ dysfunctions, encompassing respiratory distress, acute kidney injury and gastrointestinal ischemia. Some patients may even require extracorporeal life support to bridge to recovery, transplantation or decision making (1)(2)(3). Consequently, the cardiac intensive care unit (ICU) demands robust organ support capabilities. The prevailing challenges in this domain encompass the maintaining organ functionality in critically ill individuals and the prudent use of extracorporeal life support technologies.In this special issue, we have invited researchers from around the globe to focus on the issue of organ support in cardiac ICU. We have received a total of 26 submissions, indicating that this field has indeed captured the interest and attention of the academic community. We would like to take this opportunity to express our sincere appreciation to all contributors and readers.We are pleased to accept 8 papers on the research topic of Organ Support in Cardiac Intensive Care (https://www.frontiersin.org/research-topics/60649/organ-support-incardiac-intensive-care), comprising 4 original research articles , 1 review, and 3 case reports. The studies mainly focused on hemodynamic monitoring, extracorporeal membrane oxygenation (ECMO) and Intra-aortic Balloon Pump (IABP) support.Massive pulmonary embolism (MPE) is one of the leading causes of preventable cardiovascular mortality and morbidity. ECMO may hold a pivotal role in the treatment of MPE (4)(5)(6). Mark G. Davies and colleagues have explored the utility of ECMO for MPE. They discussed the pathophysiology of MPE and how ECMO can provide hemodynamic support by oxygenating the blood and right ventricular unloading. The review also scrutinized experimental models, clinical guidelines, and the different strategies for using ECMO in MPE, such as a bridge to intervention or as standalone therapy. Despite the potential benefits, the application of ECMO is not without risks, including systemic inflammation and hemorrhagic complications.IABP is sometimes coupled with Venoarterial extracorporeal membrane oxygenation (VA-ECMO) to treat patients with cardiogenic shock. Haiwang Wang et al attempted to evaluate the impact of the IABP strategy on survival rates and the incidence of vascular complications in adult patients with cardiogenic shock who are undergoing VA -ECMO therapy. This systematic review analyzed the effectiveness of VA-ECMO treatment, with and without the addition of IABP, in adult patients experiencing cardiogenic shock. The study reavled that the concomitant use of IABP with VA-ECMO was associated with a decrease in-hospital mortality. However, no statistically significant differences were observed between the two treatment groups,including rates of neurological, gastrointestinal, limb-related, bleeding, and infectious complications The evaluation of left ventricular (LV) function is crucial in management of patients with VA -ECMO, however, the most widely used measures of LV performance are substantially load-dependent (7). Bálint Károly Lakatos et al conducted a multicenter observational study named MIX-ECMO, which aimed to assess the LV contractility in patients undergoing VA-ECMO using a non-invasive myocardial work index. The study sought to determine the prognostic value of this index in predicting the success of weaning from VA-ECMO support and explored its potential advantages over conventional parameters of LV function.Dynamic arterial elastance (Eadyn) has emerged as a parameter of interest for predicting the hemodynamic response to various interventions (8). In the systematic review and meta-analysis by Xiaoyang Zhou et al, the authors investigated the predictive performance of Eadyn for mean arterial pressure (MAP) response to norepinephrine weaning in mechanically ventilated patients suffering from vasoplegic syndrome. In this study, Eadyn was found to be a reliable predictor of MAP response, with a high area under the hierarchical summary receiver operating characteristic curve (AUHSROC). This indicated its potential use in guiding clinical decisions regarding norepinephrine weaning.Hongbo Huai et al investigated diaphragmatic dysfunction in patients following cardiac surgery, aiming to assess its impact on prognosis and identify potential risk factors. The study revealed a 40.7% incidence of early postoperative diaphragmatic dysfunction, which might be associated with a higher likelihood of requiring noninvasive ventilation and increased oxygen support. Although the difference was not statistically significant, there was a trend towards longer intensive care unit and postoperative hospital stays for those with diaphragmatic dysfunction. These findings are crucial for guiding respiratory care and rehabilitation approaches during the postoperative phase of cardiac surgery (9).In the research collection of Organ Support in Cardiac Inten -Abstract Truncated-
cardiac & cardiovascular systems